A Predictive Tool for Personalizing Psychosis Treatment
Dr. Susana Ochoa from the Sant Joan de Déu Research Institute · Parc Sanitari Sant Joan de Déu leads a European project to offer personalized metacognitive training for people with psychosis by developing a learning algorithm.
-
A potential therapeutic target has been discovered for the rare metabolic disease PMM2-CDG
The collaboration of three research groups has made it possible to identify cellular and molecular pathways affected in patients with PMM2-CDG through the development of a transcriptomic data analysis technology using patient-derived fibroblasts.
-
New discoveries about the EWS-FLI oncogene involved in the development of Ewing's tumor
Researchers from IRSJD · SJD Barcelona Children’s Hospital and IRB Barcelona have successfully developed Drosophila models expressing the EWS-FLI oncogene at varying levels, overcoming previous toxicity challenges and enabling detailed study of Ewing sarcoma's oncogenic pathways.
-
Preg-MEDAS questionnaire: questions for a healthier pregnancy
A study conducted by IRSJD and IDIBAPS introduces the new preg-MEDAS questionnaire, which measures the positive impact of the Mediterranean diet on pregnant women. The study demonstrated that women following the Mediterranean diet significantly reduced their blood pressure.
-
New Therapeutic Targets to Fight Type 2 Diabetes
A study led by Dr Manuel Vázquez-Carreras presents an integrative view of the most outstanding advances in understanding this process and helping to identify new pharmacological targets in the fight against type 2 diabetes mellitus.
-
Automated learning app improves accessibility to medulloblastoma classification
A team from the Sant Joan de Déu Research Institute, Sant Joan de Déu Hospital, and the Polytechnic University of Catalonia, has developed an artificial intelligence-based application to make the classification of medulloblastoma subgroups more accessible, less costly, and faster
-
The first living pediatric patients brain tissue laboratory in Europe
King's College London and Sant Joan de Déu have formalized an agreement to develop a new living pediatric patients brain pediatric tissue laboratory. The laboratory is set to open at the beginning of 2025 and will be led by Dr. Óscar Marín, a neuroscience expert.
-
Genetic basis of ADHD and autism spectrum disorder impacts on children's school performance
A study coordinated by the Institut de Recerca Sant Joan de Déu and the Vall d'Hebron Research Institute, within the SJD MIND Schools program, has analyzed the impact of the genetic basis of these disorders on the mental health and academic outcomes of children and adolescents.
-
Research into treatments to combat obesity and excessive sleepiness in children with Prader-Willi syndrome
Researchers from Sant Joan de Déu have promoted various research projects in recent years to advance the understanding of Prader-Willi syndrome and study new treatments for children affected by this rare disease.